Raman Spectrometer Design Patents: Leaders, Trends & White Space 2026
- No single owner controls the field. the ranked leader holds 153 of 4,382 records and the top 5 combined account for just 12.8% of all records in scope.
- Filing has cooled from its 2019 high. output peaked at 289 records that year and fell -50% from 2021 (270) to 2024 (136), the last year with complete data.
- Medical and pharma classes now outweigh core optics. A61K, C07D, A61B and A61P medicinal/therapeutic classes each appear on well over 300 records alongside the G01N and G01J instrumentation core.
Filing growth compares 2021 (270 records) with 2024 (136) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 4,382 records in scope (CR5), not by the ranked leaders only.
What this dataset covers
Raman spectrometer design sits at the intersection of optical instrumentation and the applications that consume its output. The search scope combines core hardware terms — laser wavelength selection, detector cooling, spectral resolution — with terms tied to how a Raman signal is actually used once collected, such as fluorescence background suppression and calibration standard practice. That pairing is why the IPC composition below shows as much pharmaceutical and diagnostic activity as it does instrumentation proper.
4,382 records fall inside the 2015–2026 window used here, with United States, WIPO/PCT and EPO as the dominant receiving offices. Publication lags filing by roughly 18 months, so the most recent one or two years in any trend understate real filing activity and should not be read as a slowdown on their own.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trend and technology composition
Two views of the same 4,382 records: how filing volume has moved year over year, and which IPC subclasses the claims actually sit in.
Filing rose to a 2019 peak, then pulled back
Annual output climbed from 153 records in 2017 to a peak of 289 in 2019, then declined; the 2021-to-2024 span alone shows a -50% move (270 to 136). 2025 and 2026 figures are still incomplete due to publication lag and should not be read as a continued fall.
Instrumentation core plus a large medicinal overlay
G01N (material analysis) and G01J (radiation/light measurement) anchor the instrumentation side at 44.3% and 29.8% of all 4,382 records respectively. A61K, C07D, A61B and A61P together show that a large share of filings route Raman hardware claims through pharmaceutical formulation, diagnostic and therapeutic-activity classes rather than pure optics — a record can carry several classes, so these percentages overlap rather than sum to 100%.
Shares are the percentage of the 4,382 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Raman Spectrometer Design with Eureka
This page is one run against one query. Ask Eureka your own question about raman spectrometer design and every answer comes back with the patent numbers behind it.
Try EurekaA recent filing shows where design activity is heading
Identifying substances stored in containers utilizing a portable Raman probe (US12687497B2)
The filing describes a portable Raman probe that uses axicon and grating-axicon optical elements to collect spectra from substances behind non-opaque barriers using off-axis techniques, paired with a spectra-refinement machine-learning model that turns raw or noisy collected samples into refined spectra.Assignee: N.F. Falcon LLC.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US20040010103A1 | Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom | 491 |
| 2 | US20210113121A1 | Non-invasive medical monitoring device for blood analyte measurements | 386 |
| 3 | US20040073120A1 | Systems and methods for spectroscopy of biological tissue | 329 |
| 4 | US6205354B1 | Method and apparatus for noninvasive measurement of carotenoids and related chemical substances in biological… | 303 |
| 5 | US5842995A | Spectroscopic probe for in vivo measurement of raman signals | 299 |
| 6 | US6002476A | Chemical imaging system | 296 |
| 7 | US20120123205A1 | Additional systems and methods for providing real-time anatomical guidance in a disgnostic or therapeutic pro… | 273 |
| 8 | WO1993003672A1 | Optical histochemical analysis, in VIVO detection and real-time guidance for ablation of abnormal tissues usi… | 217 |
| 9 | US5850623A | Method for standardizing raman spectrometers to obtain stable and transferable calibrations | 215 |
| 10 | US5266498A | Ligand binding assay for an analyte using surface-enhanced scattering (SERS) signal | 213 |
Citation counts favour older filings that have had more time to accumulate citations inside the corpus; treat them as a signal of influence, not of current relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the concentration and citation data indicate
Ownership is dispersed, the citation leaders are old, and co-filing activity is thin — three signals that together describe a field still open to new entrants.
No dominant gatekeeper
The leading assignee holds 153 records and the fifth-ranked holds 62 — a steep drop-off rather than a plateau. With the top 5 combined at only 12.8% of all records in scope, most of the field sits with single- or few-filing entrants rather than a small controlling group.
Volume down from the 2019 peak
Output peaked at 289 records in 2019 and has since declined, with the 2021-to-2024 window showing a -50% move from 270 to 136 records. Because 2025-2026 data is still filling in from publication lag, this should be read as a real pullback from peak activity, not evidence of a field in terminal decline.
Influence sits with older filings
The most-cited records in this set date back well before the 2015 window opens for new filings, spanning polymerization catalysts through early non-invasive Raman monitoring devices. High citation counts here mark foundational prior art that later filers had to design around, not current state of the art.
Collaboration is limited and clustered
Only 10 co-assignee pairs appear across the dataset, and the strongest pairings link a small number of repeat filers with named inventors or closely held affiliates rather than broad industry consortia. That pattern points to in-house development as the norm rather than joint filing.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to raman spectrometer design, with the prior art for and against each one.
A dispersed field with a long tail
The ranked leader files at roughly 2.5x the tenth-place volume, but even that leader controls a small slice of the total. Momentum data suggests most of the historically active filers have gone quiet in the latest year.
A clear but narrow leader
The leading assignee's 153 records outpace the fifth-ranked filer's 62 by a wide margin, showing genuine concentration at the very top. But 153 records out of 4,382 in scope is still a small fraction of the field, leaving room for new entrants to build a competitive position.
Most activity sits outside the ranked leaders
Even extending the count to the top 10 filers only reaches 18.7% of all 4,382 records in scope. The remainder is spread across the other 90 ranked companies and a large number of unranked, single- or few-filing entities.
Historic leaders have largely stopped filing
Recent-year momentum among several previously active assignees shows either zero or a single filing in the latest year, consistent with the broader post-2021 pullback. This does not necessarily mean exit from the field, given publication lag, but it does mean recent competitive signal has to be read from newer or unranked filers instead.
| Assignee | Recent year | YoY |
|---|---|---|
| Massachusetts Institute of Technology | 1 | — |
| ChemImage Corp | 0 | — |
| Pfizer Inc | 0 | — |
| Celgene Corp | 0 | — |
| SICPA Holding SA | 0 | — |
| Chevron Phillips Chemical Company LP | 0 | — |
| National University of Singapore | 0 | — |
| Regents of the University of California | 0 | -100% |
Where to take this analysis
The dataset points to specific questions worth running deeper before committing R&D or freedom-to-operate budget.
Map claim scope on the citation leaders
The five most-cited records anchor prior art going back decades in tissue spectroscopy and catalyst polymerization. Before filing in adjacent probe or detector designs, check how their claims have been narrowed or challenged since.
Explore citation trees in EurekaTrack the post-2021 pullback by sub-class
The -50% move from 2021 to 2024 is an aggregate figure; whether it is concentrated in one IPC class or spread evenly changes where fresh filing opportunity actually sits.
Run a class-level trend query in EurekaWatch unranked and new entrants
With the ranked leaders holding under a fifth of all records combined, competitive signal in this field increasingly comes from filers outside the top 100 list, including very recent filings like the 2026 portable probe record.
Set up assignee alerts in EurekaCommon questions about Raman spectrometer patents
The dataset ranks 100 companies, and even the top holder controls only 153 of the 4,382 records in scope. Concentration is genuinely low: the top 5 assignees combined account for just 12.8% of all records, and the top 10 combined reach 18.7%. This means no single company's patent position can be treated as a blanket barrier to entry, though specific claim families from the leading filers still need individual review.
Filing peaked in 2019 at 289 records and has declined since, with the complete 2021-to-2024 window showing a -50% drop from 270 to 136 records. Because patent publication typically lags filing by about 18 months, the 2025 and 2026 figures in any dataset are still incomplete and should not be read as continued decline. The honest read is a pullback from a 2019 high, not a field going quiet.
Because the search scope combines core hardware terms like laser wavelength selection and detector cooling with terms describing how Raman signals are applied, such as fluorescence background suppression. That pulls in A61K (medicinal preparations, 15.1% of records), A61B (diagnosis and surgery, 11.5%) and A61P (therapeutic activity, 8.8%) alongside the instrumentation-focused G01N and G01J classes. A single record often carries both an instrumentation class and a medical-application class.
US12687497B2, filed by N.F. Falcon LLC and published 2026-07-21, claims a portable Raman probe using axicon and grating-axicon optical elements to collect spectra from substances behind non-opaque barriers via off-axis techniques, combined with a machine-learning model that refines noisy raw spectra. It is one of the most recent filings in this dataset and signals where design activity is currently heading: occluded-sample sensing plus computational spectral cleanup, rather than incremental optics-only improvements. Anyone designing a competing portable probe with axicon optics or off-axis barrier sensing should review its specific claim scope directly.
The composition data shows the instrumentation core (G01N, G01J) is heavily claimed, but sub-areas that combine hardware with newer computational or application-specific elements — such as machine-learning-based spectral refinement or calibration methods decoupled from medical diagnostics — carry thinner overlap with the dominant classes. Catalysis-linked Raman monitoring under B01J also sits at a comparatively low 4.7% of records despite steady industrial interest in reaction monitoring. These are starting points for a freedom-to-operate search, not guarantees of open space.
Research Raman Spectrometer Design in depth with Eureka
Go past this page: query the whole raman spectrometer design corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.